ArticleJMIR medical informatics2024
An Automatic and End-to-End System for Rare Disease Knowledge Graph Construction Based on Ontology-Enhanced Large Language Models: Development Study.
Article in JMIR medical informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- OntoCodex: a multi-agent biomedical ontology enrichment framework.npj health systems · 2026Article
- Persona-Driven Data Augmentation for Disease Name Recognition Across Rare and General Disease Corpora: Comparative Evaluation Study.JMIR medical informatics · 2026Article
- Artificial intelligence for pediatric rare disease diagnosis: a multimethod study integrating published evidence and clinician interviews.BMC medical informatics and decision making · 2026Article
- A Multimodal Biomedical Transformer Fusion Network for Disease-Level Rare-Disease-Inheritance Classification Using Ontology-Enriched Text, Metadata, and Gene Associations.Biomedicines · 2026Article
- Leveraging large language models for rare disease named entity recognition.PLOS digital health · 2026Article
- Application of knowledge graphs in rare disease research.Frontiers in public health · 2026Review
- Empowering standardized residency training in China through large language models: problem analysis and solutions.Annals of medicine · 2025Article
- Large Language Model-Enhanced Drug Repositioning Knowledge Extraction via Long Chain-of-Thought: Development and Evaluation Study.JMIR medical informatics · 2025Article
- A Survey on Unifying Large Language Models and Knowledge Graphs for Biomedicine and Healthcare.KDD : proceedings. International Conference on Knowledge Discovery & Data Mining · 2025Article
- Diagnostic Accuracy of a Custom Large Language Model on Rare Pediatric Disease Case Reports.American journal of medical genetics. Part A · 2025Article
- Combining Implementation and Data Sciences to Accelerate Evidence Integration into Healthcare - ImpleMATE.F1000Research · 2025Article
- Exploring the reversal curse and other deductive logical reasoning in BERT and GPT-based large language models.Patterns (New York, N.Y.) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rare diseases affect millions worldwide but sometimes face limited research focus individually due to low prevalence. Many rare diseases do not have specific International Classification of Diseases, Ninth Edition (ICD-9) and Tenth Edition (ICD-10), codes and therefore cannot be reliably extracted from granular fields like "Diagnosis" and "Problem List" entries, which complicates tasks that require identification of patients with these conditions, including clinical trial recruitment and research efforts. Recent advancements in large language models (LLMs) have shown promise in automating the extraction of medical information, offering the potential to improve medical research, diagnosis, and management. However, most LLMs lack professional medical knowledge, especially concerning specific rare diseases, and cannot effectively manage rare disease data in its various ontological forms, making it unsuitable for these tasks. Objective: Our aim is to create an end-to-end system called automated rare disease mining (AutoRD), which automates the extraction of rare disease-related information from medical text, focusing on entities and their relations to other medical concepts, such as signs and symptoms. AutoRD integrates up-to-date ontologies with other structured knowledge and demonstrates superior performance in rare disease extraction tasks. We conducted various experiments to evaluate AutoRD's performance, aiming to surpass common LLMs and traditional methods. Methods: AutoRD is a pipeline system that involves data preprocessing, entity extraction, relation extraction, entity calibration, and knowledge graph construction. We implemented this system using GPT-4 and medical knowledge graphs developed from the open-source Human Phenotype and Orphanet ontologies, using techniques such as chain-of-thought reasoning and prompt engineering. We quantitatively evaluated our system's performance in entity extraction, relation extraction, and knowledge graph construction. The experiment used the well-curated dataset RareDis2023, which contains medical literature focused on rare disease entities and their relations, making it an ideal dataset for training and testing our methodology. Results: On the RareDis2023 dataset, AutoRD achieved an overall entity extraction F1-score of 56.1% and a relation extraction F1-score of 38.6%, marking a 14.4% improvement over the baseline LLM. Notably, the F1-score for rare disease entity extraction reached 83.5%, indicating high precision and recall in identifying rare disease mentions. These results demonstrate the effectiveness of integrating LLMs with medical ontologies in extracting complex rare disease information. Conclusions: AutoRD is an automated end-to-end system for extracting rare disease information from text to build knowledge graphs, addressing critical limitations of existing LLMs by improving identification of these diseases and connecting them to related clinical features. This work underscores the significant potential of LLMs in transforming health care, particularly in the rare disease domain. By leveraging ontology-enhanced LLMs, AutoRD constructs a robust medical knowledge base that incorporates up-to-date rare disease information, facilitating improved identification of patients and resulting in more inclusive research and trial candidacy efforts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.